L-glutamine protects against enterohemorrhagic Escherichia coli infection by inhibiting bacterial virulence and enhancing host defense concurrently

Microbiol Spectr. 2023 Dec 12;11(6):e0097523. doi: 10.1128/spectrum.00975-23. Epub 2023 Oct 10.

Abstract

The type 3 secretion system (T3SS) was obtained in many Gram-negative bacterial pathogens, and it is crucial for their pathogenesis. Environmental signals were found to be involved in the expression regulation of T3SS, which was vital for successful bacterial infection in the host. Here, we discovered that L-glutamine (Gln), the most abundant amino acid in the human body, could repress enterohemorrhagic Escherichia coli (EHEC) T3SS expression via nitrogen metabolism and therefore had potential as an antivirulence agent. Our in vitro and in vivo evidence demonstrated that Gln could decline EHEC infection by attenuating bacterial virulence and enhancing host defense simultaneously. We repurpose Gln as a potential treatment for EHEC infection accordingly.

Keywords: L-glutamine; antivirulence; enterohemorrhagic Escherichia coli; host defense; nitrogen metabolism; type 3 secretion system.

MeSH terms

  • Enterohemorrhagic Escherichia coli* / metabolism
  • Escherichia coli Infections* / drug therapy
  • Escherichia coli Infections* / microbiology
  • Escherichia coli Infections* / prevention & control
  • Escherichia coli Proteins* / genetics
  • Gene Expression Regulation, Bacterial
  • Glutamine / metabolism
  • Humans
  • Intestinal Diseases*
  • Type III Secretion Systems / metabolism
  • Virulence
  • Virulence Factors / metabolism

Substances

  • Virulence Factors
  • Glutamine
  • Escherichia coli Proteins
  • Type III Secretion Systems